Drug Patent Expirations for March 2014

Drug Patent Expirations for March 2014 Tradename Applicant Generic Name Patent No. EVISTA Lilly raloxifene hydrochloride 5,478,847 EVISTA Lilly raloxifene hydrochloride RE39050 EVISTA Lilly raloxifene hydrochloride 5,972,383 EVISTA Lilly raloxifene hydrochloride 5,811,120 AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER Bayer Hlthcare moxifloxacin hydrochloride 5,607,942 EMEND Merck And Co Inc fosaprepitant dimeglumine 5,512,570 AVELOX Bayer Hlthcare moxifloxacin hydrochloride 5,607,942 EXUBERA Pfizer insulin recombinant human 5,997,848 EXUBERA Pfizer insulin recombinant human 6,592,904 EXUBERA Pfizer insulin recombinant human 6,051,256 EXUBERA Pfizer insulin recombinant human 6,737,045 EXUBERA Pfizer insulin recombinant human 6,423,344 IMITREX Glaxosmithkline sumatriptan 5,554,639*PED KALETRA Abbvie lopinavir; ritonavir 5,948,436*PED NORVIR Abbvie ritonavir 5,948,436*PED NORVIR Abbott ritonavir 5,948,436*PED ACCOLATE Astrazeneca zafirlukast 5,612,367 LIPTRUZET Merck Sharp Dohme atorvastatin calcium; ezetimibe 5,846,966*PED ZETIA Msd Intl Gmbh ezetimibe 5,846,966*PED VYTORIN Msd Intl ezetimibe; simvastatin 5,846,966*PED MONISTAT 1 COMBINATION PACK Insight Pharms miconazole nitrate 5,514,698 ZORTRESS Novartis everolimus 6,440,990*PED RAPAMUNE Pf Prism Cv sirolimus 5,536,729*PED BUSULFEX Otsuka Pharm busulfan 5,430,057*PED LIDODERM Teikoku Pharma Usa lidocaine 5,741,510 BUSULFEX Otsuka Pharm busulfan 5,559,148*PED *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.